All Products
  • Antibiotics
    • Penicillins
    • Cephalosporins
    • Macrolides
    • Other Antibiotics
  • Central Nervous System
    • Others
    • Analgesics & Antipyretics
    • Non-steroidal anti-inflammatory drugs
  • Musculoskeletal system
  • Respiratory System
    • Cough & Cold Preparations
  • Allergy & Immune System
    • Histamin
  • Gastrointestinal System
  • Cardiovascular System
  • Corticosteroid Hormones
  • Herbal Medicines
  • Health Supplements
    • Nutrition & Release Body Heat
    • Support & Detoxify the Liver
    • Support Brain Function & Sedatives
    • Support Kidney Function & Improve Male Sexual Frigidity
    • Antioxidant, Inhibit the Free Radicals
    • Antidiabetic Agents
    • Gastrointestinal System
    • Cough & Cold
    • Skeletal - Joints
  • Oral Antidiabetic Agents
  • Vitamins & Minerals

Hotline

0273 3872 972

VN
ABOUT US
Overview
History
Mission & Vision
Organization Structure
MEDIA
News
Library
Careers
INVESTOR RELATIONS
Tipharco Shares Information
Disclosure
Financial Statements
General Shareholders Meeting
Corporate Governance
Annual Reports
Newsletters
Event Calendar
Contacts
INVOICE SEARCH
All products
Antibiotics
Penicillins Cephalosporins Macrolides Other Antibiotics
Central Nervous System
Others Analgesics & Antipyretics Non-steroidal anti-inflammatory drugs
Musculoskeletal system
Respiratory System
Cough & Cold Preparations
Allergy & Immune System
Histamin
Gastrointestinal System
Cardiovascular System
Corticosteroid Hormones
Herbal Medicines
Health Supplements
Nutrition & Release Body Heat Support & Detoxify the Liver Support Brain Function & Sedatives Support Kidney Function & Improve Male Sexual Frigidity Antioxidant, Inhibit the Free Radicals Antidiabetic Agents Gastrointestinal System Cough & Cold Skeletal - Joints
Oral Antidiabetic Agents
Vitamins & Minerals

  1. Home
  2. INVESTOR RELATIONS
  3. General Shareholders Meeting
  4. 2025

General Shareholders Meeting

2025
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011

Documents and Forms for the 2025 Annual General Meeting of Shareholders

Based on the Resolution of the Board of Directors No. 10/2025/NQ-HĐQT-DTG dated March 27, 2025, shareholders are kindly requested to refer to the meeting documents and forms as follows:

  • Meeting documents;
  • Proxy Form and Nomination Form for Board of Directors and Supervisory Board members.
  • Proxy Form (Word);
  • Nomination Form for Board of Directors Member (Word);

  • Minutes of Shareholder Group Meeting for Board of Directors Nomination (Word);

  • Nomination Form for Supervisory Board Member (Word);

  • Minutes of Shareholder Group Meeting for Supervisory Board Nomination (Word);

  • Candidate Profile Form (Word).
  • Tipharco Shares Information
  • Disclosure
  • Financial Statements
  • General Shareholders Meeting
  • Corporate Governance
  • Annual Reports
  • Newsletters
  • Event Calendar

Tipharco Pharmaceutical Joint Stock Company (“Tipharco”) was established in 1976 and is currently on UPCOM (Stock code: DTG) since 2017. Tipharco has 3 pharmaceutical factories: non-Beta-lactam, Beta-lactam, and herbal medicine factories that meet GMP-WHO standards.

CONTACTS
Address: No.26 Street 40, Thao Dien Ward, Thu Duc City, Hochiminh City
Factory: Lot 08, 09, Tan My Chanh Small Industrial and Handicraft Cluster, Ward 9, My Tho City, Tien Giang Province, Vietnam

Telephone: 0273.3872.972

Fax: 0273.3885.040

Email: info@tipharco.vn
  • Overview
  • News
  • Careers
  • Contacts

Công ty Cổ Phẩn

Dược Phẩm Tipharco

Giấy CNĐKDN số:1200100557

  • Antibiotics
  • Analgesics & Antipyretics
  • Non-steroidal anti-inflammatory drugs
  • Respiratory System
  • Allergy & Immune System
  • Gastrointestinal System
  • Cardiovascular System
  • Corticosteroid Hormones
  • Herbal Medicines
  • Support & Detoxify the Liver
  • Antidiabetic Agents
  • Cough & Cold
  • Oral Antidiabetic Agents
Copyright © 2022 Tipharco.. All rights reserved